1 minute read
Clinical Service Lines
Oncology Research
CommonSpirit Health Research Institute plays a key role nationally in conducting oncology research within our national network of community hospitals and clinics.
Advertisement
The CommonSpirit Research Institute Oncology research network at a glance includes 29 sites across seven states that are actively enrolling in National Cancer Institute, industry- and other grant-funded trials, with nearly 1300 total patients enrolled.
This national endeavor is supported by 30 Principal Investigators and 33 FTEs across all sites. These trials are interventional, observational and patient registries.
Oncology Research Council
Dr. P. Emanuel
Dr. S. Siddique
Dr. J. Croley (SE)
Dr. Bruce Lin (PNW)
Dr. Ben Musher (TX)
Dr. Aidnag Diaz (SW)
Dr. Parminder Sidhu (So. Cal)
Dr. Peter Silberstein (Midwest)
Jill Tapper, Director
Diana Pak (PNW)
Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
This protocol is a case-control, multicenter, diagnostic study to collect blood samples to support the development of blood-based screening tests for multiple cancers. The primary objective is to compare blood samples from cancer case subjects and non-cancer control subjects in order to develop and characterize blood-based multiomics tests in specific cancer types or as a combination of multiple cancers.
Seven CommonSpirit Health sites in Kentucky and California are enrolling now, with our Kentucky sites being noted by Freenome as top enrolling sites nationally. The Vallania study was CommonSpirit’s first multi-site industry funded protocol brought to the Institute directly by the sponsor (Freenome) and opened at multiple CommonSpirit sites with a single IRB, contract, budget, and operational review.
